Skip to main content

At-Home Smell Test Can Help ID Risk for Cognitive Impairment

Medically reviewed by Carmen Pope, BPharm. Last updated on April 2, 2025.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, April 2, 2025 -- The digital remote AROMHA Brain Health Test (ABHT) can discriminate cognitively normal (CN) older adults from those with cognitive impairment, according to a study published online March 24 in Scientific Reports.

Benoît Jobin, Ph.D., from Massachusetts General Hospital in Boston, and colleagues developed the ABHT, an at-home odor identification, discrimination, memory, and intensity assessment, which was self-administered among 127 CN individuals (English and Spanish speaking), 34 participants with subjective cognitive complaints (SCC), and 19 participants with mild cognitive impairment (MCI). The test was self-administered remotely at home under unobserved (CN participants) and observed (CN, SCC, and MCI) modalities and in-person with a research assistant present (CN, SCC, and MCI).

The researchers found that with age, there was a decrease in odor memory, identification, and discrimination scores. In addition, compared with the CN and SCC groups, the MCI group had lower olfactory identification and discrimination, independent of age, sex, and education.

"These results suggest that the ABHT could be used in clinical research settings in different languages to explore the utility of olfactory biomarkers to predict the presence of blood-based, image-based, or cerebrospinal fluid-based biomarkers of neurodegenerative disease and longitudinal development of clinical symptoms," the authors write.

Several authors disclosed financial ties to Aromha.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Swept-Source Anterior Segment OCT Can Help Distinguish Early Childhood Glaucoma

FRIDAY, May 23, 2025 -- The noninvasive swept-source anterior-segment optical coherence tomography (SS-ASOCT) can diagnose early-onset childhood glaucoma, according to a study...

Semaglutide Plus Intensive Behavioral Therapy Most Beneficial for Weight Loss

FRIDAY, May 23, 2025 -- Weight loss treatment combining personalized semaglutide with intensive behavioral therapy (IBT) yields weight loss similar to that reported in...

Higher Social Media Use Tied to Subsequent Depressive Symptoms in Youth

FRIDAY, May 23, 2025 -- Higher social media use is associated with greater subsequent depressive symptoms in children and adolescents, according to a study published online May 21...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.